Impact of renal function on bleeding risk in patients with non-valvular atrial fibrillation treated with direct oral anticoagulants: Subanalysis of the DIRECT registry

被引:0
|
作者
Hirata, A. [1 ]
Sotomi, Y. [1 ]
Kobayashi, T. [1 ]
Amiya, R. [1 ]
Hirayama, A. [1 ]
Higuchi, Y. [1 ]
机构
[1] Osaka Police Hosp, Cardiovasc Div, Osaka, Japan
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P4753
引用
收藏
页码:2957 / 2957
页数:1
相关论文
共 50 条
  • [21] Evaluation of the predictive performance of bleeding risk scores in patients with non-valvular atrial fibrillation on oral anticoagulants
    Beshir, S. A.
    Aziz, Z.
    Yap, L. B.
    Chee, K. H.
    Lo, Y. L.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2018, 43 (02) : 209 - 219
  • [22] Prescribing Errors With Direct Oral Anticoagulants and Their Impact on the Risk of Bleeding in Patients With Atrial Fibrillation
    Raccah, Bruria Hirsh
    Erlichman, Yevgeni
    Pollak, Arthur
    Matok, Ilan
    Muszkat, Mordechai
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2021, 26 (06) : 601 - 610
  • [23] A comparison of front-line oral anticoagulants for the treatment of non-valvular atrial fibrillation: effectiveness and safety of direct oral anticoagulants in the FANTASIIA registry
    Asuncion Esteve-Pastor, Maria
    Miguel Rivera-Caravaca, Jose
    Ruiz-Ortiz, Martin
    Muniz, Javier
    Roldan-Rabadan, Inmaculada
    Otero, Deborah
    Lopez-Galvez, Raquel
    Cequier, Angel
    Bertomeu-Martinez, Vicente
    Badimon, Lina
    Anguita, Manuel
    Lip, Gregory Y. H.
    Marin, Francisco
    EXPERT OPINION ON PHARMACOTHERAPY, 2022, 23 (12) : 1457 - 1465
  • [24] Real-life behaviour of direct oral anticoagulants in a Spanish cohort with non-valvular atrial fibrillation: Refase Registry
    Navarro-Almenzar, Begona
    Jose Cerezo-Manchado, Juan
    Caro-Martinez, Cesar
    Garcia-Candel, Faustino
    Flores Blanco, Pedro Jose
    Elvira Ruiz, Gines
    Andreu Cayuelas, Jose Miguel
    Arregui Montoya, Francisco
    Cascales, Almudena
    Lova Navarro, Alejandro
    Garcia Alberola, Arcadio
    Pascual Figal, Domingo Andres
    Bailen Lorenzo, Jose Luis
    Manzano-Fernandez, Sergio
    CURRENT MEDICAL RESEARCH AND OPINION, 2019, 35 (12) : 2035 - 2041
  • [25] Bleeding Risk in Non-Valvular Atrial Fibrillation Patients Receiving Direct Oral Anticoagulants and Warfarin: A Systematic Review and Meta-Analysis of Observational Studies
    Wang, Yimin Pearl
    Kehar, Rohan
    Iansavitchene, Alla
    Lazo-Langner, Alejandro
    BLOOD, 2019, 134
  • [26] Direct oral anticoagulants in non-valvular atrial fibrillation in elderly: for a treatment adapted to patient profile
    Tayaa, Said
    Berrut, Gilles
    de Decker, Laure
    Chevalet, Pascal
    GERIATRIE ET PSYCHOLOGIE NEUROPSYCHIATRIE DE VIEILLISSEMENT, 2018, 16 (03): : 229 - 240
  • [27] The development and validation of a multivariable model to predict the bleeding risk score for patients with non-valvular atrial fibrillation using direct oral anticoagulants in the Arab population
    AlAmmari, Maha
    Sultana, Khizra
    Alturaiki, Abdulrahman
    Thomas, Abin
    AlBabtain, Monirah
    AlAyoubi, Fakahr
    Richi, Hanie
    PLOS ONE, 2021, 16 (05):
  • [28] Renal outcomes in Asian patients receiving oral anticoagulants for non-valvular atrial fibrillation
    Shahzada, Tayyab Salim
    Guo, Cosmos L.
    Lee, Alex P. W.
    HONG KONG MEDICAL JOURNAL, 2022, 28 (01) : 24 - 32
  • [29] Utilization patterns of direct oral anticoagulants in Medicare beneficiaries with cancer and non-valvular atrial fibrillation
    Ardeshirrouhanifard, Shirin
    An, Huijun
    Goyal, Ravi K.
    Segal, Jodi B.
    Alexander, G. Caleb
    Mehta, Hemalkumar B.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 392 - 393
  • [30] Prescribers' perceptions of benefits and limitations of direct acting oral anticoagulants in non-valvular atrial fibrillation
    Generalova, Daria
    Cunningham, Scott
    Leslie, Stephen J.
    Rushworth, Gordon F.
    Mciver, Laura
    Stewart, Derek
    PHARMACY PRACTICE-GRANADA, 2020, 18 (02): : 1 - 6